Dengue Fever :: Unique mouse joins battle against dengue fever
A mosquito-borne disease often known as ?break-bone fever? has found a new enemy in a unique type of mouse.
A mosquito-borne disease often known as ?break-bone fever? has found a new enemy in a unique type of mouse.
Avastin (bevacizumab), Roche’s innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.
The South Africa Department of Health has noted the study into the role of nutrition with regard to the management of HIV and AIDS and TB that was released by the Academy of Science of South Africa (ASSAf) yesterday.
Physicians at the University of Alabama at Birmingham (UAB) have discovered the first successful treatment to stop progressive kidney function loss in patients suffering from Fabry disease. David Warnock, M.D., director of the UAB Division of Nephrology, led the team, whose results are published in the September edition of the Journal of the American Society of Nephrology.
St Mirren FC defender Ryan McCay kicked off the expansion of ?Starting Fresh?, NHS Greater Glasgow and Clyde?s unique pharmacy-led smoking cessation project, in pharmacies throughout Clyde.
The City of Houston is taking action to protect Houstonians from the substantial health risks associated with secondhand smoke. The City Council has passed an ordinance that will make all workplaces and public spaces smoke free starting September 1, 2007.
The Centers for Medicare & Medicaid Services (CMS) issued a final rule to refine and update the Home Health Prospective Payment System (HH PPS) for Calendar Year (CY) 2008.
Vocal cord dysfunction (VCD) is the sudden, abnormal narrowing closure of the vocal cords during inhalation causing obstruction of the airflow, and is characterized by a noise that can mimic the sound of wheezing. A VCD attack can easily be mistaken for an asthma attack though it does not respond to asthma medications.
The UK urgently needs to reorganise stroke services to improve outcomes for patients, argues a senior doctor in this week?s BMJ.
Cancer stem cell researchers at the James P. Wilmot Cancer Center at the University of Rochester Medical Center have received grants totaling $1.7 million to pursue the study of experimental therapies that target leukemia stem cells.